We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nanofluidic Diffraction Grating Technique for DNA Amplification May Replace PCR

By LabMedica International staff writers
Posted on 21 Sep 2016
A team of Japanese biophysicists suggests replacing the RT-PCR (real time polymerase chain reaction) technique with a rapid label-free detection method for real-time DNA amplification using a nanofluidic diffraction grating.

Investigators at Nagoya University (Japan) based their strategy for quantifying DNA amplification in a label-free manner on observations of intensity changes of diffracted light derived from the passage of a laser beam through nanochannels embedded in a microchannel; the ability to diffract the beam is a basic characteristic of nanochannels.

In practice, they fabricated 2.7 micron deep, 200 nanometer wide periodic nanochannels embedded in microchannels, which were etched on fused silica substrates by electron beam lithography, photolithography, and plasma etching. More...
For an incident laser beam they used a modulated 532 nanometer laser to amplify a specific component extracted from random or background noise.

They investigators reported in the August 17, 2016, online edition of the journal Scientific Reports that numerical simulations revealed that the diffracted light intensity change in the nanofluidic diffraction grating was attributed to the change of refractive index. Using the technique, they demonstrated the first case reported to date for label-free detection of real-time DNA amplification, such as specific DNA sequences from tubercle bacilli (TB) and human papillomavirus (HPV). Since the system allowed quantification of the initial concentration of amplified DNA molecules ranging from one femtomolar to one picomolar, the investigators expect that it will offer a new strategy for developing fundamental techniques of medical applications.

"Our system also measures DNA amplification at the relatively low temperature of 34 degrees Celsius and without the need for thermal cycles," said contributing author Dr. Noritada Kaji, associate professor of engineering at Nagoya University. "Because it has the potential to be constructed as a single chip and can detect sample volumes as small as one microliter, which is 100-1,000 times less than conventional detectors are capable of, it is particularly suited to development as a miniaturized form of diagnostics and microbe detection."

Related Links:
Nagoya University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.